PRAC meeting highlights 13-16 January 2025
17/01/2025
Medicines for human use
Pharmacovigilance risk assessment committee (PRAC)
The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing and monitoring safety issues for human medicines.
The current PRAC highlights from the January 2025 meeting provides an update on medicines containing semaglutide and the risk of rare eye conditions.